(Q45239833)

11 December 2017

title

The metabolic syndrome and inflammation: association or causation? (English)

1 reference

11 December 2017

1 reference

Esposito K

1

1 reference

11 December 2017

Giugliano D

series ordinal

2

1 reference

11 December 2017

publication date

1 October 2004

1 reference

Nutrition, Metabolism, and Cardiovascular Diseases

11 December 2017

published in

1 reference

11 December 2017

volume

14

1 reference

11 December 2017

issue

5

1 reference

11 December 2017

page(s)

228-232

1 reference

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam.

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic american indians: the Strong Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study.

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Obesity, metabolic syndrome, and coronary atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Association of low interleukin-10 levels with the metabolic syndrome in obese women

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

New Markers of Inflammation and Endothelial Cell Activation

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Body mass index, diabetes, and C-reactive protein among U.S. adults

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes : the Leiden 85-Plus Study

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

The lipopolysaccharide-activated toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Association of hypoadiponectinemia with coronary artery disease in men

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Inflammation in cardiovascular disease: cart, horse, or both?

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

1 reference

https://api.crossref.org/works/10.1016%2FS0939-4753%2804%2980048-6

7 January 2021

10.1016/S0939-4753(04)80048-6

Identifiers

DOI

1 reference

11 December 2017

1 reference